A one-day workshop for people left behind by the HIV response in Nigeria is underway today to orient participants to the new ambitious treatment target – the 90-90-90 – and how best it can be achieved by 2020.
The workshop organised by UNAIDS will allow the people left behind and stakeholders supporting the HIV response to share ideas on innovative ways of getting more people counselled, tested and placed on treatment in Nigeria.
“The aim of this workshop is to give people left behind in Nigeria a meaningful role in ensuring that they understand, they own and they drive the achievement of the 90-90-90 target by 2020. This is the only way that will put Nigeria on the path of ending the AIDS epidemic by 2030,” said Dr Bilali Camara, UNAIDS Country Director for Nigeria and UNAIDS Focal Point for Economic Community Of West African States (ECOWAS).
The workshop, which is taking place in Abuja, has attracted a spectrum of representatives of people left behind, among others the vulnerable women and girls.
A special workshop will also take place for Nigerian adolescents on the 90-90-90 target. Adolescents are a major group left behind by the national HIV response.
Participants at the workshop also include representatives of the National Agency for the Control of AIDS (NACA), the National AIDS and STI Control Programme (NASCP), the Network of People Living with HIV/AIDS in Nigeria (NEPWHAN), civil society organisations, United Nations Agencies, and development partners supporting the HIV response in Nigeria like PEPFAR, USAID, CDC and the AIDS Health Care Foundation.
The 90-90-90 treatment target was launched at a high-level political session of the 20th International AIDS Conference held in July 2014 in Melbourne, Australia, when the UNAIDS Executive Director, Michel Sidibé, called for a new set of treatment targets by 2020. The target involves ensuring that:
- 90 per cent of all people living with HIV will know their HIV status;
- 90 per cent of all people with diagnosed HIV infection will receive sustained antiretroviral therapy; and
- 90 per cent of all people receiving antiretroviral therapy will have viral load suppression.